Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Camitta

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Transplantation|June 1, 1983
Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donorR J Duquesnoy, A Zeevi, M Marrari, et al.
Cancer Treatment Reports|October 1, 1982
Doxorubicin-vincristine therapy for Wilms' tumor: a pilot studyB Camitta, L Kun, M Glicklich, et al.
Bone Marrow Transplantation|May 1, 1990
Autoimmune thyroiditis after bone marrow transplantationD T Wyatt, L G Lum, J Casper, et al.
Bone Marrow Transplantation|January 1, 1992
Unrelated donor marrow transplants for severe acquired aplastic anemiaJ Hows, R Szydlo, C Anasetti, et al.
Blood|December 1, 1978
Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patientsR Parkman, J Rappeport, B Camitta, et al.
Leukemia|November 21, 1998
Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group studyM J Borowitz, J Rubnitz, M Nash, et al.
Cancer|June 1, 1976
The role of irradiation in central nervous system treatment and prophylaxis for acute lymphoblastic leukemiaA Dritschilo, J R Cassady, B Camitta, et al.
Cancer|September 1, 1991
Osteoblastoma response to chemotherapyB Camitta, R Wells, A Segura, et al.
Haematology and Blood Transfusion|January 1, 1987
Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factorsH Weinstein, H Grier, R Gelber, et al.
Investigational New Drugs|May 1, 1991
Toxicity trials of amsacrine (AMSA) and etoposide +/- azacitidine (AZ) in childhood acute non-lymphocytic leukemia (ANLL): a pilot studyC P Steuber, T Holbrook, B Camitta, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Transplantation|June 1, 1983
Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donorR J Duquesnoy, A Zeevi, M Marrari, et al.
Cancer Treatment Reports|October 1, 1982
Doxorubicin-vincristine therapy for Wilms' tumor: a pilot studyB Camitta, L Kun, M Glicklich, et al.
Bone Marrow Transplantation|May 1, 1990
Autoimmune thyroiditis after bone marrow transplantationD T Wyatt, L G Lum, J Casper, et al.
Bone Marrow Transplantation|January 1, 1992
Unrelated donor marrow transplants for severe acquired aplastic anemiaJ Hows, R Szydlo, C Anasetti, et al.
Blood|December 1, 1978
Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patientsR Parkman, J Rappeport, B Camitta, et al.
Leukemia|November 21, 1998
Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group studyM J Borowitz, J Rubnitz, M Nash, et al.
Cancer|June 1, 1976
The role of irradiation in central nervous system treatment and prophylaxis for acute lymphoblastic leukemiaA Dritschilo, J R Cassady, B Camitta, et al.
Cancer|September 1, 1991
Osteoblastoma response to chemotherapyB Camitta, R Wells, A Segura, et al.
Haematology and Blood Transfusion|January 1, 1987
Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factorsH Weinstein, H Grier, R Gelber, et al.
Investigational New Drugs|May 1, 1991
Toxicity trials of amsacrine (AMSA) and etoposide +/- azacitidine (AZ) in childhood acute non-lymphocytic leukemia (ANLL): a pilot studyC P Steuber, T Holbrook, B Camitta, et al.
Pageof 8